Effects of Individualized iTBS on Upper Limb Function After Stroke.

This document provides information about a clinical trial conducted by Qilu Hospital of Shandong University in China. The trial aims to investigate the effectiveness of individualized intermittent theta burst stimulation (iTBS) in stroke patients with upper extremity impairment. The trial will involve 159 participants aged 18-80 who have been diagnosed with a first-time stroke within the past 1-3 months. The primary completion date for data collection is estimated to be March 19, 2026. The trial is not yet recruiting participants. [Extracted from the article]